HFA Premium Access

Prognostic impact of transition of left ventricular ejection fraction in patients at risk for heart failure: Insights from the CHART-2 Study

Congress Presentation

About the speaker

Doctor Hajime Aoyanagi

Tohoku University, Sendai (Japan)
0 follower

29 more presentations in this session

Prognostic value of NT-proBNP added to clinical parameters to predict two-year prognosis of chronic heart failure patients with mid-range and reduced ejection fraction, a report from FAR NHL registry

Speaker: Professor J. Spinar (Brno, CZ)

Thumbnail

Prospective observational study on heart failure: one-year follow-up results of NATURE-HF (NAtional Tunisian REgistry of Heart Failure) outcome registry

Thumbnail

Sex-related differences in inflammation-associated biomarkers and their predictive utility for new-onset heart failure

Speaker: Doctor L. Meems (Groningen, NL)

Thumbnail

The patient journey of heart failure patients in Belgian hospitals

Speaker: Miss C. Verhestraeten (Brussels, BE)

Thumbnail

Frequency of cardiac and non cardiac monocomorbidity in heart failure outpatients stratified by ejection fraction phenotype: a single tertiary university center experience

Speaker: Associate Professor G. Giamouzis (Larissa, GR)

Thumbnail

Access the full session

Poster Session 2 - Chronic Heart Failure – Epidemiology, Prognosis, Outcome

Speakers: Doctor H. Aoyanagi, Professor J. Spinar, Doctor L. Meems, Miss C. Verhestraeten, Associate Professor G. Giamouzis
Thumbnail

About the event

Image

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb